Regularly published financial reports are always preceded by a silent period of 30 days, during which Remedy does not issue statements on the financial position, business operations, markets or prospects.

During the silent period, the senior management of the company does not meet with investors, analysts or other capital market representatives, nor do they give interviews on the financial position of the company.

Disclosure of annual accounts or interim reports are disclosed on the Investor Calendar.

Silent period and closed window12.1.–12.2.2019
Financial statements release 1.1.–31.12.201812.2.2019
2018 annual report and financial statementsWeek 13
Annual general meeting (preliminary date)8.4.2019
Silent period and closed window13.7.–13.8.2019
H1 2019 half-year report13.8.2019